ExpreS2ion CEO interviewed, CFO provides update at life science investor conference, Analysguiden publishes research report
Hørsholm, Denmark, 27 November 2023 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces that ExpreS2ion CEO Bent Frandsen participated in a Finwire interview, CFO Keith Alexander participated in the Økonomisk Ugebrev Life Science Investor Conference on 22 November, and Analysguiden has published a research report on ExpreS2ion in November.An interview with CEO Bent Frandsen, hosted by Finwire, and a presentation by CFO Keith Alexander at the Økonomisk Ugebrev Life Science Investor Conference on 22 November 2023, can both be found on the